ResultsIQ › Latest results › Chemfab Alkalis Limited

Chemfab Alkalis Limited Q2 FY26 results deck summary

NSE: CHEMFAB · BSE: 541269

Results deck of 1 Nov 2025, summarised by AI from the filing.

Q2 FY26 revenue ₹70.66 cr, down 10.56% YoY; ECU realisation recovery expected from Q4 onwards.

Key takeaways

Q2 FY26 results Revenue ₹70.66 cr (Q2 FY25: ₹79.00 cr, -10.56%); operational EBITDA ₹8.44 cr (Q2 FY25: ₹12.66 cr, -33.33%); PBT ₹2.27 cr (Q2 FY25: ₹4.21 cr, -46.08%).
Driver OPVC pipes expansion and Jal Jeevan Mission extension till 2028 drive demand.

Chemfab Alkalis Limited Q1 FY27 results

As filed: Revenue ₹73.2 cr (−20% year on year), EBITDA ₹10.1 cr (−16% year on year), PAT ₹5.7 cr (+91% year on year), EBITDA margin 13.9% (+80 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

Q4 FY26: Revenue ₹74.8 cr (−19% year on year), EBITDA ₹8.5 cr (−43% year on year), PAT ₹0.5 cr, EBITDA margin 11.4% (−491 bps). Score 14 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend. EBITDA margin fell 491 bps year on year. Other income 228% of PBT. Tax rate 60%. Share price after the results: −9.2% in 30 days (Nifty 500: +1.0%).
Q3 FY26: Revenue ₹68.1 cr (−19% year on year), EBITDA ₹1.9 cr (−84% year on year), PAT −₹4.5 cr (−300% year on year), EBITDA margin 2.9% (−1,000 bps). Score 11 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 1000 bps year on year. Revenue fell 12% from last quarter. Share price after the results: −5.6% in 30 days (Nifty 500: +0.4%).
Q2 FY26: Revenue ₹77.0 cr (−6% year on year), EBITDA ₹6.0 cr (−40% year on year), PAT −₹2.0 cr, EBITDA margin 7.8% (−440 bps). Score 15 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend. EBITDA margin fell 440 bps year on year. Revenue fell 16% from last quarter. Share price after the results: −15.9% in 28 days (Nifty 500: +0.9%).
Q1 FY26: Revenue ₹92.0 cr (+19% year on year), EBITDA ₹12.0 cr (+50% year on year), PAT ₹3.0 cr (+200% year on year), EBITDA margin 13.0% (+265 bps). Score 84 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 265 bps year on year. Tax rate 40%. Share price after the results: −16.2% in 29 days (Nifty 500: −2.0%).
Q4 FY25: Revenue ₹92.0 cr (+12% year on year), EBITDA ₹15.0 cr (+25% year on year), PAT −₹9.0 cr (−63% year on year), EBITDA margin 16.3% (+167 bps). Score 63 of 100, In line with trend. Revenue and EBITDA growth were well above the company's own trend; profit before exceptional items growth was well below it. EBITDA margin rose 167 bps year on year. Profit fell 25% from last quarter. Share price after the results: −9.9% in 30 days (Nifty 500: +1.8%).
Q3 FY25: Revenue ₹84.0 cr (−2% year on year), EBITDA ₹12.0 cr (−14% year on year), PAT ₹2.0 cr (−71% year on year), EBITDA margin 14.3% (−199 bps). Score 20 of 100, Below trend. Revenue and EBITDA growth were below the company's own trend; profit growth was well below it. EBITDA margin fell 199 bps year on year. Other income 75% of PBT. Tax rate 50%.
Q2 FY25: Revenue ₹82.0 cr (+3% year on year), EBITDA ₹10.0 cr (−17% year on year), PAT −₹1.0 cr (−125% year on year), EBITDA margin 12.2% (−280 bps). Score 5 of 100, Below trend. EBITDA margin fell 280 bps year on year. Other income 100% of PBT. Tax rate 200%. Not enough history for a trend yet: scored on growth alone. Profit fell 200% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Chemfab Alkalis Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.